
USF-LVHN SELECT
PD18-07 RISK FACTORS FOR PROGRESSION AND SURVIVAL IN MRCC PATIENTS WITH NO EVIDENCE OF DISEASE FOLLOWING CYTOREDUCTIVE NEPHRECTOMY WITH METASTASES DIRECTED THERAPY
Publication/Presentation Date
5-2024
Volume
211
Issue
5
First Page
435
Last Page
435
Published In/Presented At
Shapiro DD, Ghasemzadeh A, Peyton CC, Manley BJ, Sirard RB, Robertson ND, et al. PD18-07 RISK FACTORS FOR PROGRESSION AND SURVIVAL IN MRCC PATIENTS WITH NO EVIDENCE OF DISEASE FOLLOWING CYTOREDUCTIVE NEPHRECTOMY WITH METASTASES DIRECTED THERAPY. Journal of Urology [Internet]. 2024 May 1 [cited 2025 Mar 13];211(5S):e435. Available from: https://doi.org/10.1097/01.JU.0001008596.32809.c5.07
Disciplines
Medical Education | Medicine and Health Sciences
Department(s)
USF-LVHN SELECT Program, USF-LVHN SELECT Program Students
Document Type
Article